Anti-angiogenic therapy based on inhibition of VEGF/VEGF receptor is believed to be powerful clinical strategy in the treatment of cancer, especially for liver cancer which is a highly vascular tumor [67], [68].The inhibitory effect of PP on VEGF suggests the anti-angiogenic activities of PP and its potential implication in anti-angiogenic therapy. This evidence concerns the gene VEGFA and cancer.